NPI: 1336349539 · LAS VEGAS, NV 89119 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/25/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/25/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,146 | $295K |
| 2019 | 19,474 | $207K |
| 2020 | 11,852 | $228K |
| 2021 | 8,867 | $439K |
| 2022 | 16,733 | $435K |
| 2023 | 10,545 | $278K |
| 2024 | 5,476 | $360K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 36,641 | 1,764 | $2.24M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,788 | 801 | $432.00 |
| J1756 | Injection, iron sucrose, 1 mg | 6,813 | 875 | $184.04 |
| A4657 | Syringe, with or without needle, each | 3,275 | 1,058 | $117.90 |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,515 | 508 | $64.95 |
| 83540 | 484 | 206 | $0.00 | |
| 85048 | 1,282 | 532 | $0.00 | |
| 83970 | 993 | 414 | $0.00 | |
| 85041 | 1,291 | 556 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 552 | 205 | $0.00 |
| 82108 | 171 | 78 | $0.00 | |
| 83550 | 282 | 140 | $0.00 | |
| 82728 | 526 | 232 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 170 | 79 | $0.00 |
| 82746 | 121 | 52 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 189 | 50 | $0.00 |